FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 01/01/2019 |
3. Issuer Name and Ticker or Trading Symbol
Bunge LTD [ BG ] |
|||||||||||||
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 12,081(1) | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Stock Options (Right to buy) | (2) | 02/28/2021 | Common Stock | 4,500 | $71.2 | D | |
Stock Options (Right to buy) | (3) | 03/05/2023 | Common Stock | 4,500 | $74.33 | D | |
Stock Options (Right to buy) | (4) | 02/28/2024 | Common Stock | 4,200 | $79.47 | D | |
Stock Options (Right to buy) | (5) | 02/27/2025 | Common Stock | 4,575 | $81.68 | D | |
Stock Options (Right to buy) | (6) | 03/01/2026 | Common Stock | 5,300 | $50.07 | D | |
Stock Options (Right to buy) | (7) | 03/08/2027 | Common Stock | 6,800 | $81 | D | |
Stock Options (Right to buy) | (8) | 02/28/2028 | Common Stock | 8,300 | $75.99 | D |
Explanation of Responses: |
1. Includes (i) 1,634 restricted stock units ("RSUs") that were granted to the insider on March 1, 2016 and 107 RSUs acquired pursuant to a dividend reinvestment feature that will vest on March 1, 2019, (ii) 1,100 RSUs that were granted to the insider on March 8, 2017 and 48 RSUs acquired pursuant to a dividend reinvestment feature that will vest on March 8, 2020, (iii) 2,500 RSUs that were granted to the insider on February 28, 2018 and 56 RSUs acquired pursuant to a dividend reinvestment feature that will vest in three annual installments as to 25%, 25% and 50% of the RSUs beginning on February 28, 2019, and (iv) 5,000 RSUs that were granted to the insider on November 15, 2018 and 42 RSUs acquired pursuant to a dividend reinvestment feature that will vest on November 15, 2021. One RSU is convertible into one share of Bunge Ltd. common stock. |
2. This option became exercisable in three equal annual installments beginning March 2, 2012. |
3. This option became exercisable in three equal annual installments beginning March 5, 2014. |
4. This option became exercisable in three equal annual installments beginning February 28, 2015. |
5. This option became exercisable in three equal annual installments beginning February 27, 2016. |
6. This option is exercisable in three equal annual installments beginning March 1, 2017. |
7. This option is exercisable in three equal annual installments beginning March 8, 2018. |
8. This option is exercisable in three equal annual installments beginning February 28, 2019. |
Remarks: |
/s/ John Tropeano, Attorney-in-Fact | 01/09/2019 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |